55
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study

, , , &
Pages 37-48 | Published online: 08 Jul 2009

References

  • Maumenee AE. Symposium: Macular Diseases. Pathogenesis. Trans Am Acad Ophthalmol Otolaryngol. 1965;69:691–699.
  • Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: 1. Generalconcepts and classification.Am J Ophthalmol. 1967;63: 573–585.
  • Gass JDM. Pathogenesis of disciform detachment of theneuroepithelium: III. Senile disciform macular degeneration. Am J Ophthalmol. 1967;63:617–644.
  • Sarks SH. Ageing and degeneration in the macular region: A clinico-pathological study. Br J Ophthalmol. 1976;60:324–341.
  • Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology. I 985;92:6 15–627.
  • Van der Schaft TL, Mooy CM, De Bruijn WC, Oron FG, Mulder PG, De Jong PT. Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology. 1992;99: 278–286.
  • Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: The involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985; 223:69–76.
  • Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1986;27: 364–371.
  • Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: Ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol. 1987;225:70–76.
  • Gehrs KM, Heriot WJ, De Juan E. Transmission electron microscopic study of a subretinal choroidal neovascular membrane due to age-related macular degeneration. Arch Ophthalmol. 1992;110:833–837.
  • Grossniklaus HE, Martinez JA, Brown VB, Lambert HM, Sternberg PJ, Capone AJ, et al. Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;114:464–472.
  • Van der Schaft TL, Mooy CM, De Bruijn WC, De Jong PT. Early stages of age-related macular degeneration: An immunofluorescence and electron microscopy study. Br J Ophthalmol. 1993;77:657–661.
  • Seregard S, Algvere PV, Berglin L. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch Clin Exp Ophthalmol. 1994;232:325–329.
  • Penfold PL, Liew SC, Madigan MC, Provis JM. Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38: 2125–2133.
  • Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000:70:441–449.
  • Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385–414.
  • Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging. 1995;16:523–530.
  • Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology. 1995; 45:1441–1445.
  • McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology. 1996;47: 425–432.
  • Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging. 1996; 17:377–384.
  • Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging. 1996;17:385–395.
  • Klaver CC, Ott A, Hofman A, Assink JJ, Breteler MM, De Jong PT. Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study. Am J Epidemiol. 1999;150:963–968.
  • Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583–587.
  • Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. '995; I 02: 1450-1460.
  • Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103:357–364.
  • Klein R, Davis M, Magli Y, Segal P, Klein B, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128–1134.
  • Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–374.
  • Wang JJ, Mitchell P, Smith W, Cumming RG. Bilateral involvement by age related maculopathy lesions in a population. Br J Ophthalmol. 1998;82:743–747.
  • Klein R, Klein BEK, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study [see comments]. Ophthalmology. 1997;104:7–21.
  • Penfold PL, Wong JG, Gyory J, Billson FA. Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Exp Ophthalmol. 200 I ;29: 188–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.